Normal human keratinocytes possess a finite replicative lifespan. Most advanced squamous cell carcinomas (SCCs), however, are immortal, a phenotype that is associated with p53 and INK4A dysfunction, high levels of telomerase and loss of heterozygosity (LOH) at several genetic loci, suggestive of the dysfunction of other mortality genes. We show here that human chromosome 6 specifically reduces the proliferation or viability of a human SCC line, BICR31, possessing LOH across the chromosome. This was determined by an 88% reduction in colony yield (Po0.001), following the reintroduction of an intact normal chromosome 6 by monochromosome transfer. Deletion analysis of immortal segregants using polymorphic markers revealed the loss of a 2.9 Mbp interval, centred on marker D6S1045 at 6q14.3-q15, in 6/ 19 segregants. Crucially, allelic losses of this region were not identified in control hybrids constructed between chromosome 6 and the BICR6 SCC cell line that is heterozygous for chromosome 6 and which showed no reduction in colony formation relative to the control chromosome transfers. This indicates that the minimally deleted region at D6S1045 is not the result of fragile sites, a recombination hot spot, or a feature of the monochromosome transfer technique. LOH of D6S1045 was found in 2/9 immortal SCC lines and was part of a minimally deleted region of line BICR19. Furthermore, allelic imbalance, consistent with LOH, was detected in 3/ 17 advanced SCCs of the tongue. These results suggest the existence of a suppressor of SCC immortality and tumour development at chromosome 6q14.3-q15, which is important to a subset of human SCCs.
Introduction
Human keratinocytes possess a finite proliferative lifespan, but in contrast most advanced squamous cell carcinomas (SCCs) are immortal (Edington et al., 1995) . Genetic analysis of the immortal phenotype has revealed several genetic alterations that are important to the process including the dysfunction of p53, INK4A and a gene on chromosome 3p that represses telomerase activity (Loughran et al., 1997; Parkinson et al., 1997) . In addition, microcell-mediated monochromosome transfer (MMCT) experiments suggest that other cancer mortality genes may exist (Ning et al., 1991; Wang et al., 1992; Casey et al., 1993; Koi et al., 1993; Ogata et al., 1993; Hensler et al., 1994; Rimessi et al., 1994; Sandhu et al., 1994 Sandhu et al., , 1996 Sasaki et al., 1994; Uejima et al., 1995; England et al., 1996; Karlsson et al., 1996; Robertson et al., 1998; Cuthbert et al., 1999; Steenbergen et al., 2001; Forsyth et al., 2002) . Loss of heterozygosity (LOH) at some of these chromosomal loci supports a role for the dysfunction of these putative mortality genes in the immortality of human SCCs (Loughran et al., 1997; Forsyth et al., 2002) . One of these is chromosome 6 (Loughran et al., 1997) , which has also been shown to carry mortality genes for SV40-transformed human fibroblasts and human ovarian carcinoma cells mapping to 6q21-qter (Sandhu et al., 1994; Banga et al., 1997) and 6q14-q21 (Sandhu et al., 1996) , respectively.
Previous investigations have used the technique of monochromosome transfer to induce proliferation arrest in human and rodent cancer lines (Ning et al., 1991; Wang et al., 1992; Casey et al., 1993; Koi et al., 1993; Ogata et al., 1993; Hensler et al., 1994; Rimessi et al., 1994; Sandhu et al., 1994 Sandhu et al., , 1996 Sasaki et al., 1994; Uejima et al., 1995; England et al., 1996; Karlsson et al., 1996; Banga et al., 1997; Robertson et al., 1998; Cuthbert et al., 1999; Steenbergen et al., 2001) and have attempted to identify the genes responsible by the extensive deletion analysis of segregant colonies that continue to proliferate (see for example, Rimessi et al., 1994; England et al., 1996; Karlsson et al., 1996; Robertson et al., 1998; Cuthbert et al., 1999; Forsyth et al., 2002) . These studies have shown that, in some instances, the commonly deleted regions contain known antiproliferative genes (England et al., 1996; Robertson et al., 1998) or tumour suppressor genes (Cheng et al., 1998; Lo et al., 2001) . A similar strategy aided the identification of the gene responsible for Leigh syndrome (Zhu et al., 1998) . However, many other similar studies have failed to identify antiproliferative genes by this method. It is possible that many deletions of the transferred, wild-type chromosome are the result of the MMCT technique (Fujikawa-Yamamoto et al., 1994) , oxidative damage (Turker et al., 1999) , recombinational hotspots (Benitez et al., 1997) or fragile sites (Engelman et al., 1998) and in none of the previous studies has a control set of hybrids been analysed to rule this out. In both MMCT-derived immortal segregants (England et al., 1996) and in vivo LOH studies (Wu et al., 1999) , deletions are found in regions other than the INK4A locus, even when INK4A is the relevant gene on the chromosome (England et al., 1996) . These problems have most likely confounded attempts to identify genes by deletion analysis in the past.
We have used MMCT and deletion analysis to test for, and map, a mortality gene for human SCC on chromosome 6, but we have paid special attention to the problems associated with artifactual or spontaneous chromosomal breaks. To do this, we took advantage of a panel of SCC lines that could be characterized with respect to LOH (Loughran et al., 1997) and introduced the chromosome into lines that either did, or did not, show LOH of chromosome 6.
The results show that chromosome 6 was inhibitory to SCC colony formation only in the BICR31 cell line that showed LOH on chromosome 6. A number of immortal segregants harboured deletions of 2.9 Mbp at 6q14.3-q15 that were not found in control hybrids. This region was also lost in a subset of SCC cell lines and advanced SCCs in vivo. Collectively, these results suggest the existence of a mortality gene at this locus that is relevant to the development of some SCCs.
Results
Monochromosome transfer of a normal chromosome 6 reduces colony yield in a cell line with LOH on chromosome 6 Table 1 shows that the cell line BICR 31, which possesses LOH over the entire length of chromosome 6, formed only 12% of the number of hygromycinresistant colonies as the same monochromosome transfer into a line with no LOH on chromosome 6, BICR6 (Po0.001). The result is not explained by the inability of the BICR31 line to receive intact human chromosomes, since BICR31 formed 60% of the number of BICR6 colonies when chromosome 3 was transferred and 78% of the number of BICR6 colonies when chromosome 11 was transferred (P>0.1). The two lines were matched in that they had both deleted the INK4A locus, had dysfunctional p53, wild-type Ras and possessed a similar number of epidermal growth factor receptors (Clark et al., 1993; Stanton et al., 1994; Loughran et al., 1997, see Table 2 ). The relative reduction in colony formation when chromosome 6 is transferred into line BICR31 is therefore suggestive of an antiproliferative gene on this chromosome whose dysfunction may contribute to its immortal phenotype.
Deletion analysis of the chromosome 6-BICR6 and -BICR31 hybrids reveals both specific and nonspecific regions of exogenous allele loss
The availability of a large number of polymorphic microsatellite markers enables the analysis of the transferred chromosomes at the molecular level. No detectable deletions were observed in 12/19 immortal segregants of chromosome 6-BICR31 hybrids and therefore cannot provide any mapping information at this stage. Figure 1a shows the analysis of the transferred chromosome 6 in the seven informative chromosome 6-BICR31 immortal segregants. In these seven segregants, we noted four regions that showed higher than background frequencies of loss. Only one of them, region 3 at 6q14.3-q15 (D6S1045), was specific to BICR31 as assessed by the Fisher's exact test applied to all 19 segregants (Po0.07; see Table 3 ). The others were lost at the same frequency or greater, in the control chromosome 6-BICR6 hybrids (see Figure 1b) . The other regions, region 1 at 6p21-p22 (P ¼ 0.261), region 2 at 6q12 (P ¼ 0.341) and region 4 at 6q21 (P ¼ 0.256), are therefore considered to be of lesser significance and may reflect the tendency of these regions to be lost during the transfer technique, or to other events such as favoured sites of recombination and/or breakage which are coselected with the regions carrying the biologically active gene(s). This result also emphasizes the requirement for negative control recipient lines when using this (Sandhu et al., 1996) , making them our lead intervals. However, the region centred on D6S1045 is more frequently (31% of the segregants versus 26%) and specifically (Po0.07 versus P ¼ 0.256) deleted than the region 4. D6S416 is lost in the chromosome 6-BICR31 segregants, but the closely adjacent markers, D6S302 and D6S474, are also lost in the control chromosome 6-BICR6 hybrids (D6S416, D6S302 and D6S474 map to the same position on the radiation hybrid map). Furthermore, region 4 is never lost independently of region 3. Region 4 is also distinct from other putative senescence gene regions at 6q16.3-q21 (Morelli et al., 1997) and such a large number of minimally deleted, but distinct intervals at 6q16.3-q21 might be consistent with this area being a fragile site (Azzalin et al., 1997; Green et al., 1988) . Indeed, this has been reported (Green et al., 1988) . Furthermore, 6q21 is also a frequent site of chromosome healing, as evidenced by the presence of interstitial telomere repeats (Azzalin et al., 1997) . The loss of region 4 microsatellites D6S302 and D6S474 in BICR6 control hybrid 6.10 is consistent Figure 1 Genetic alterations on chromosome 6 in immortal hybrids, (a) Deletion analysis of immortal BICR31 hybrids showing four interstitial regions of LOH regions 1-4 (shaded region, R1-R4). The positions of the previously described senescence loci on chromosome 6, SEN6 (Sandhu et al., 1994; Banga et al., 1997) , SEN 6A (Sandhu et al., 1996) and SEN BK (Morelli et al., 1997) In all cases, J, allele retention; , allele loss and , noninformative A mortality locus for squamous cancer maps to 6q14.3-q15 SA Fitzsimmons et al with this possibility. Interestingly, YACs transferred into mammalian cells from the 6q16.3 to q21 region also have a tendency to be unstable (Morelli et al., 1997) . For these reasons, we consider the antiproliferative SCC gene to be more likely contained within the region centred on D6S1045 and flanked by two retained markers D6S1627 and D6S1004 in segregant HYTK6-BICR31.15 ( Figure 1c Cytogenetic analysis of chromosome 6-BICR hybrids to determine integrity of exogenous chromosome 6
A total of 12 chromosome 6-BICR31 immortal hybrids lacked detectable deletions of the exogenous chromosome 6, even when subject to intensive microsatellite analysis and this has been reported before (England et al., 1996; Cuthbert et al., 1999) . The usual explanations for this are microdeletions (England et al., 1996; Robertson et al., 1998) or methylation (Wang et al., 1992; England et al., 1996) of the relevant gene on the wild-type chromosome, sometimes involving only one exon. More rarely, dysfunction of unknown downstream effector genes occurs (Karlsson et al., 1996) . We do not know which, if any, of these explanations applies to our data. However, it is also possible that the transferred, wild-type chromosome 6 had become rearranged to inactivate the mortality gene. Therefore, we subjected the seemingly intact, segregant hybrids and the segregant HYTK6-BICR31.15, which possesses only a small deletion (Figure 1a, c) , to further analysis using chromosome painting (Figure 2) . A total of 92% of the BICR31 recipient cells show two completely painted copies of chromosome 6 (Figure 2a ) and the remainder three copies (data not shown). Surprisingly, however, instead of carrying one extra intact copy of chromosome 6 as expected, HYTK6-BICR31.15 and all the other 12 segregants analysed, contained two to three extra copies of chromosome 6 (Figure 2b ) and had an average of 90 chromosomes (range 70-153) compared to the 44 of the parental BICR31 (range 42-46). We are confident that the results are not because of the coincident fusion of BICR31 recipients with both microcells and other BICR31 cells, since the transfers of chromosome 3 into BICR31 and chromosome 6 into BICR6, carried out at the same time as the chromosome 6-BICR31 transfers, did not result in such ploidy changes (data not shown). The result is not explained by the preferential ability of a tetraploid subset of BICR31 to form proliferating colonies following MMCT of chromosome 6, since many of the hybrid mitoses contained 120-150 chromosomes, not the tetraploid 90. Instead, the reintroduction of an extra copy of chromosome 6 into BICR31 may restore a cell cycle checkpoint function, which in the absence of other checkpoints (see Table 2 ) leads to increased ploidy and possibly proliferation arrest or death. However, it is equally possible that the increase in ploidy may aid the segregation of the immortal phenotype in these hybrids and the unavailability of chromosome spreads from nonclonogenic cells renders it impossible to distinguish between these possibilities.
LOH studies show that D6S1045 is deleted in a subset of SCC lines and tumours
To test the relevance of the D6S1045 locus to SCC development, we screened our panel of nine cell lines and 23 T4 tongue carcinomas (Figure 3 ). The results indicated that 2/9 lines (22%) and 3/17 (17%) tumours showed allele loss or imbalance, respectively, supporting the notion of an antiproliferative or mortality gene on chromosome 6 at this locus. Figure 3a shows allele loss and retention at D6S1045 in lines BICR19 and BICR18, respectively. Other regions of LOH were also found in BICR19 at 6q16.3-q21, and at 6q12-pter. In fact, 6q12-pter also showed LOH in two other lines BICR3 and BICR18, 4/9 in total. However, it was significant that both 6q12-pter and to a lesser extent 6q16.3-q21, but not D6S1045, were also lost in control MMCT chromosome 6-BICR6 hybrids (see Figure 1b) . Figure 3b shows examples of allelic imbalance and allelic balance at D6S1045 in three tumour samples. To test whether the D6S1045 locus might be connected to the immortal phenotype of SCC, we also tested for LOH at this region in seven mortal neoplastic keratinocyte cultures, three of which were derived from malignant biopsies (Loughran et al., 1997) . No LOH of chromosome 6q in the region of D6S1045 was found, supporting the idea that the antiproliferative gene at D6S1045 might be connected with SCC immortality, rather than other aspects of SCC development or progression. Combining these data with the deletion analysis of the immortal chromosome 6-BICR31 hybrids and the chromosome 6-BICR6 controls, the data favour the D6S1045 area of 6q14.3-q15 as the major candidate region for the SCC mortality gene.
Candidate genes
A physical map of the region 6q14.3-q15 has indicated the presence of eight known genes. Their identification and location relative to the retained markers D6S1627 and D6S1004, and the lost marker D6S1045 are shown in Figure 4 . Candidate genes include: (1) TBX18 has been identified as a member of the Tbx1 subfamily of Tbox transcription factors (Yi et al., 1999) . While the principal role of these factors is in embryonic development, members of the family have been reported to be upregulated in breast cancers (Jacobs et al., 2000) and act as cellular arrest signals in cardiogenesis (Hatcher et al., 2001) . Interestingly, a candidate osteosarcoma suppressor gene has been mapped to a region centering around TBX18 (Nathrath et al., 2002) . (2) NT5E (CD73) acts as a marker of lymphocyte differentiation and catalyses the dephosphorylation of AMP and other nucleoside monophosphates (Resta et al., 1998) . A deficiency in NT5E is characteristic of a variety of immunodeficiency diseases, for example, agammaglobulinaemia (Edwards et al., 1978) . (3) NSAP1 is a RNA binding protein, associated with NS1, whose cDNA is 80% homologous to heterogeneous nuclear ribonucleoprotein (hnRNP R) (Hassfeld et al., 1998) . It is predicted to be a 65 kDa polynucleotide binding protein whose putative function lies in the regulation of splicing and/or transport of mRNAs from the nucleus. (4) The serotonin receptor, HTR1E, is a neurotransmitter and vasoactive substance with a variety of biological effects, both in the central nervous system and in the periphery (Levy et al., 1994) . The potential candidacy of all of these genes is currently under investigation.
Discussion
Several areas of human chromosome 6 have been implicated in proliferation inhibition and replicative senescence (Sandhu et al., 1994 (Sandhu et al., , 1996 Banga et al., 1997; Morelli et al., 1997; Steenbergen et al., 2001 ), but to date no gene has been identified which accounts for the biological activity of the chromosome. We have combined the use of the classical LOH technique and microcell-mediated chromosome transfer to address whether chromosome 6 carries a mortality gene for immortal SCC-HN lines. While these approaches have been used before many times, both forms of analysis suffer from the possibility that many of the chromosomal breaks that result in allele loss may not necessarily be linked to the phenotype of immortality at all. Instead, they are merely a consequence of the inherent genetic instability of immortal human tumours, or are the result of the MMCT technique, which may itself encourage chromosomal breaks at fragile sites (Fujikawa-Yamamoto et al., 1994) . We attempted to counter this problem by taking advantage of a panel of cell lines that were extensively characterized for their allelic status on chromosome 6. One cell line, BICR31, was completely homozygous for all alleles on chromosome 6 and was thus an excellent target to test whether chromosome 6 carries a mortality gene for SCC-HN, and also to map its location using deletion analysis. As a control we used a cell line, BICR6, which was heterozygous over the entire length of the same chromosome. The control transfer of chromosome 3 or 11 into BICR6 and BICR31 yielded similar numbers of drug-resistant colonies, indicating that BICR6 and BICR31 were not greatly different in their ability to receive chromosomes by MMCT. However, when chromosome 6 was transferred into the same lines, BICR31 averaged 12% of the number of colonies of BICR6, indicating that chromosome 6 bestowed a specific proliferative disadvantage to BICR31. We subjected several immortal chromosome 6-BICR31 clones and control BICR6 hybrids to allele loss analysis and found that both groups of hybrids lost exogenous chromosome 6 material, supporting the notion that not all allele losses resulting from MMCT experiments are connected with the segregation of the phenotype of interest; in this instance, cellular immortality. It is difficult to argue that BICR6 carries a heterozygous mutation for a mortality gene on chromosome 6 or that chromosome 6 inhibits proliferation by gene dosage in this line, because the number of drugresistant colonies obtained after the transfer of chromosome 6 into BICR6 was at least as high as when other chromosomes were transferred. Significantly however, one of the deleted regions of the exogenous chromosome 6, at 6q14.3, was specific to the immortal chromosome 6-BICR31 segregants and mapped within the region proposed for the mortality gene SEN6A (Sandhu et al., 1996) . Interestingly, a chromosomal fragment spanning 6q14-q21, containing SEN6A, has been reported to elicit senescence in human ovarian cancer cells and SV40-immortalized human fibroblasts and the region shows LOH in several cancer types (Sandhu et al., 1996) . We do not know whether our gene is involved in the mortality of human SCC-HN, but the lack of LOH at 6q 14 in seven mortal cultures derived from neoplastic head and neck tissue suggests that it might be. This does not mean that the gene we have mapped and the previously reported SEN6A gene are the same, since other studies place this gene at 6q16.3 (31) or at 6q21 (Morelli et al., 1997) .
It is also of note that the region incorporating D6S1045 has been reported to show allelic imbalance in other human tumour types such as breast, prostate, B-cell lymphoma and osteosarcoma (Cooney et al., 1996; Guan et al., 1996; Sheng et al., 1996; Nathrath et al., 2002) , further supporting the possible existence of a gene in this region.
At present, we do not know exactly how the unknown gene on chromosome 6 functions to restrict BICR31 proliferation but it has no requirement for an intact INK4A locus, nor for p53, both of which are dysfunctional in BICR31 (Table 2 ) and as a result it is likely to be involved in a novel cellular mortality mechanism. Furthermore, although the introduction of chromosome 6 does repress telomerase activity in BICR31 (S. A. Fitzsimmons, unpublished data), the segregant clone HYTK6-BICR31.15, with a small deletion around D6S1045, still shows repressed telomerase activity. This result, therefore, disassociates the telomerase repressor activity of chromosome 6 (Steenbergen et al., 2001 ) from the more immediate effects of the chromosome 6 on cell proliferation. We are currently passaging the segregant HYTK6-BICR31 to test whether these hybrids eventually enter a state of replicative senescence or crisis. However, as the BICR31 line has an average telomere repeat fragment length of 6-7 kb, a significant number of mean population doublings (MPDs) may be required.
In conclusion, we have used MMCT in tandem with LOH and novel control analyses to identify a small region of chromosome 6 that may carry a mortality gene for human SCC. Eight known genes within the 2.9 Mb region at 6q14.3-q15 have been identified using a variety of resources including the University of California, Santa Cruz human genome project working draft sequence and the NCBI human map viewer, build 29.
These genes include the T-box transcription factor TBX18, the RNA-binding protein NSAP-1, the serotonin receptor 5-HT IE and connexin 25. We are currently attempting to refine the 6q14.3-q15 interval to reduce the number of genes in the region. We shall then assess their candidacy as genes involved in the immortalization of SCC-HN.
Materials and methods

Cell cultures
The biological (Edington et al., 1995) and genetic (Loughran et al., 1997) properties of the neoplastic keratinocyte cultures and lines used in this study have been described previously. The keratinocytes were cultured using Swiss 3T3 feeder layers also as described previously (Edington et al., 1995; Loughran et al., 1997) . Human fibroblasts taken from the same patients and used as a source of normal DNA (Edington et al., 1995; Loughran et al., 1997) were cultured in Dulbecco's modified Eagle's medium plus 20% foetal bovine serum. Mouse A9 cells transfected with a single copy of human chromosome 6 containing the selectable marker hygromycin B were grown in Dulbecco's modified Eagles medium plus 10% foetal bovine serum and 800 U/ml hygromycin B (Calbiochem Novachem (UK) Ltd).
MMCT
The library of hygromycin-and thymidine kinase-tagged (HYTK) human chromosomes in A92 cells has been described previously (Cuthbert et al., 1995) . Micronucleation in chromosome-donor hybrid cell lines (Cuthbert et al., 1995) was induced by mitotic block with colcemid (0.075 mg/ml) (Sigma) for 48 h. Microcells were then obtained following centrifugation at 9500 g for 1 h 15 min in the presence of cytochalasin B (l0 mg/ml) (Sigma). Crude microcell pellets were then pooled and filtered through three consecutive 5 mm polycarbonate filters (Nucleopore) in order to remove whole donor cells and larger microcells. The purified microcell pellet was then resuspended in 50 mg/ml phytohaemagglutinin in serum-free medium and applied to 70-80% confluent recipient cells (BICR 6 and 31). Plates were left for 2 h to allow attachment of microcells before fusion was performed in the presence of 42.5% polyethylene glycol (PEG 1000, Sigma) and 8.5% DMSO in serum-free medium. The HYTK-SCC hybrids were plated with hygromycin-resistant 3T3 feeder cells and allowed to form colonies for 3-4 days prior to selection of drugresistant colonies for 5 weeks in 60 or 125 U/ml of hygromycin B for BICR31 and BICR6, respectively.
Definition of a segregant
A segregant chromosome 6-BICR31 hybrid culture was classified as one that proliferated through at least 20 MPDs and DNA for microsatellite analysis was routinely isolated after around 25 MPDs. The control chromosome 6-BICR6 hybrids were cultured for the same number of doublings prior to DNA isolation.
Extraction of DNA from cultured cells DNA was extracted from 10 6 to 10 7 cells using the QIAamp tissue kit (QIAgen Ltd.) according to the manufacturer's 'blood and body fluid' protocol.
Preparation of archival T4 tongue carcinoma material for microsatellite analysis
Sections were obtained from 24 formalin-fixed, paraffinembedded T4 tongue carcinomas as described elsewhere (Going and Lamb, 1996) . Sections were digested overnight in proteinase K buffer (1 mg/ml) and then stored at À201C as unpurified lysate for subsequent use in microsatellite analysis.
Microsatellite analysis
Microsatellite primer sequences used were as listed in the Genome Database for each marker (http://www.hgmp. mrc.ac.uk/gdb/). Primers were synthesized on an Applied Biosystems 392 or 394 DNA/RNA Synthesiser using the manufacturer's protocols and reagents from Cruachem (Glasgow, Scotland, UK). All PCRs were carried out in the same way. Total reaction volumes were 25 ml containing 40 ng DNA, l0 mm Tris-HCl, pH 8.3, 50 mm KCl, 1.5 mm MgCl 2 , 10% dimethylsulphoxide, 140 ng of each primer, 200 mm concentrations of each deoxynucleotide triphosphate, 1 ml of [a 32 P]dCTP (0.1mBq/ml) and 2.5 U of Taq polymerase (Advanced Biotechnologies). Reactions were subjected to six cycles at 941C, 30 s and 601C, 30 s, followed by 25 cycles at 941C, 30 s; 551C, 30 s; and 721C, 30 s. All reactions were then subjected to a further extension of 7 min at 721C. Radiolabelled samples were run on 4-10% polyacrylamide gels under denaturing conditions. Following a drying step, gels were then exposed to X-ray film to visualize the resolved reaction products.
Statistical analyses
To test whether the loss of exogenous markers in the BICR6 and BICR31 chromosome 6 MMCT hybrids was statistically different, we subjected the data to the Fisher's exact test. Quantitative data were subjected to the nonparametric Wilcoxon-Mann-Whitney rank sum test.
Cytogenetic analysis
Metaphase chromosome spreads were prepared essentially as described previously (Mandahl, 1992) . Fluorescence in situ hybridization was performed using the Oncor Coatasome paint kit (Fantes et al., 1995) .
Abbreviations
MMCT, Microcell-mediated monochromosome transfer; LOH, loss of heterozygosity; SCC, squamous cell carcinoma.
